Regarding the speed of PSA, it also advises changes in the usual clinical practice of the management of prostate disease, since in our study we observed that changes in PSAV, increasing or decreasing, provide information on whether the prostate disease is benign or malignant. This evidence concerns the gene KLK3 and prostatitis.